![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences |
Narender Goel, Deepika Jain, Danny B. Haddad, Divya Shanbhogue |
J Stroke. 2020;22(3):306-316. Published online September 29, 2020 DOI: https://doi.org/10.5853/jos.2020.01886 |
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences Anticoagulation for Atrial Fibrillation in Patients with End- Stage Kidney Disease Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation? Anticoagulation for Atrial Fibrillation in End-stage Kidney Disease P1301CLINICAL OUTCOMES OF ORAL ANTICOAGULATION AND NO ANTICOAGULATION AMONG END-STAGE RENAL DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS WITH ATRIAL FIBRILLATION: A SINGLE-CENTER PROSPECTIVE COHORT STUDY Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease Warfarin for Atrial Fibrillation in Patients With End-Stage Renal Disease Atrial fibrillation associated hospitalizations in patients with end-stage renal disease in the United States, 2003–2012 Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease |